Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28,736,767
-
Total 13F shares
-
31,497,581
-
Share change
-
+3,149,039
-
Total reported value
-
$2,907,518,951
-
Put/Call ratio
-
130%
-
Price per share
-
$92.31
-
Number of holders
-
227
-
Value change
-
+$295,483,852
-
Number of buys
-
139
-
Number of sells
-
110
Institutional Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q2 2025
As of 30 Jun 2025 GeneDx Holdings Corp. - Common Stock (WGS) had 227 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 31,497,581 shares of stock of the company.
Largest 10 holders included Casdin Capital, LLC, Corvex Management LP, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, BlackRock, Inc., Pentwater Capital Management LP, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, T. Rowe Price Investment Management, Inc., UBS Group AG, and ORACLE INVESTMENT MANAGEMENT INC.
This table shows 228 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.